Studies of the mortality of atomic bomb survivors, report 14, 1950-2003: An overview of cancer and noncancer diseases

Radiation Research

Volumn 177, Issue 3, 2012, Pages 229-243

  Ozasa, Kotaro ^a   Shimizu, Yukiko ^a   Suyama, Akihiko ^a   Kasagi, Fumiyoshi ^a,b   Soda, Midori ^a   Grant, Eric J ^a   Sakata, Ritsu ^a   Sugiyama, Hiromi ^a   Kodama, Kazunori ^a  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^b Maruishi Daini Bldg 5F   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ATOMIC BOMB; ATOMIC BOMB SURVIVOR; BLADDER CANCER; BREAST CANCER; CANCER MORTALITY; CAUSE OF DEATH; CHILD; COLON CANCER; DOSIMETRY; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; GALLBLADDER CANCER; GROUPS BY AGE; HUMAN; INFANT; INFECTION; KIDNEY CANCER; KIDNEY PELVIS CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; LYMPHOMA; MALE; MULTIPLE MYELOMA; NEWBORN; OVARY CANCER; PANCREAS CANCER; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION CARCINOGENESIS; RADIATION DOSE; RADIATION EXPOSURE; RADIATION HAZARD; RADIATION RESPONSE; RECTUM CANCER; REVIEW; RISK ASSESSMENT; SCHOOL CHILD; SEX DIFFERENCE; SOLID TUMOR; STOMACH CANCER; URETER CANCER; UTERUS CANCER; ARTICLE; JAPAN; MIDDLE AGED; MORTALITY; RADIATION INDUCED NEOPLASM; RADIOMETRY; RISK; STATISTICS; SURVIVOR;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NUCLEAR WEAPONS; RADIOMETRY; RISK; SURVIVORS; YOUNG ADULT;

EID: 84859932436     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR2629.1     Document Type: Review

References (36)

1. Beebe GW, Ishida M, Jablon S. Studies of the mortality of A-bomb survivors. 1. Plan of study and mortality in the medical subsample (Selection 1), 1950-1958. Radiat Res 1962; 16:253-80.
2. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 2003; 160:381-407. (Pubitemid 37174507)
3. Young R, Bennett B, editors. DS02: A revised system for atomic bomb survivor dose estimation. Hiroshima: Radiation Effects Research Foundation; 2006.
4. Preston DL, Pierce DA, Shimizu Y, Cullings HM, Fujita S, Funamoto S, et al. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiat Res 2004; 162:377-89. (Pubitemid 39388159)
5. Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 2007; 168:1-64. (Pubitemid 351292925)
6. United Nations Scientific Committee on the Effects of Atomic Radiation. Effects of ionizing radiation. UNSCEAR 2006 Report, Volume 1. New York: United Nations; 2008.
7. Richardson D, Sugiyama H, Nishi N, Sakata R, Shimizu Y, Grant E, et al. Ionizing radiation and leukemia mortality among Japanese atomic bomb survivors, 1950-2000. Radiat Res 2009; 172:368-82.
8. Beebe GW, Kato H, Land CE. Studies of the mortality of A-bomb survivors. 6. Mortality and radiation dose, 1950-1974. Radiat Res 1978; 75:138-201. (Pubitemid 8373275)
9. Kato H, Johnson KG, Yano K. Mail survey on cardiovascular disease study, Hiroshima-Nagasaki. ABCC TR 19-66. Hiroshima: Atomic Bomb Casualty Commission; 1966.
10. Preston DL, Kato H, Kopecky KJ, Fujita S. Studies of the mortality of A-bomb survivors. 8. Cancer mortality, 1950-1982. Radiat Res 1987; 111:151-78. (Pubitemid 17152777)
11. Cullings HM, Fujita S, Funamoto S, Grant EJ, Kerr GD, Preston DL. Dose estimation for atomic bomb survivor studies: Its evolution and present status. Radiat Res 2006; 166:219-54 (Pubitemid 44051213)
12. Manual of the international statistical classification of diseases, injuries and causes of death: 7th revision (ICD-7). Geneva: WHO; 1957
13. International classification of diseases, revision 8 (ICD-8). Geneva: WHO; 1967
14. International classification of diseases, ninth revision (ICD-9). Geneva: WHO; 1977
15. International classification of diseases, tenth revision (ICD-10). Geneva: WHO; 1993.
16. Pierce DA, Stram DO, Vaeth M. Allowing for random errors in radiation dose estimates for the atomic bomb survivor studies: Its evolution and present status. Radiat Res 1990; 123:275-84. (Pubitemid 20327898)
17. Breslow NE, Day NE. Statistical methods in cancer research, Vol. II. The design and analysis of cohort studies. IARC Scientific Publications No. 83. Lyon: International Agency for Research on Cancer; 1988.
18. Shimizu Y, Pierce DA, Preston DL, Mabuchi K. Studies of the mortality of atomic bomb survivors. Report 12, Part II. Noncancer mortality: 1950-1990. Radiat Res 1999; 152:374-89. (Pubitemid 29463615)
19. Preston DL, Lubin JH, Pierce DA, McConney ME. Epicure users guide. Seattle: Hirosoft International Corporation; 1993.
20. Akaike H. A new look at statistical model identification. IEEE Trans Automat Control 1974; 19:716-23.
21. Little MP. Heterogeneity of variation of relative risk by age at exposure in the Japanese atomic bomb survivors. Radiat Environ Biophys 2009; 48:253-62.
22. Walsh L. Heterogeniety of variation of relative risk by age at exposure in the Japanese atomic bomb survivors. Radiat Environ Biophys 2009; 48:345-7.
23. National Research Council, Committee on the Biological Effects of Radiation. Health risks from exposure to low levels of ionizing radiation (BEIR VII Phase 2). Washington, DC: National Academies Press; 2006.
24. Jacob P, Rühm W, Walsh L, Blettner M, Hammer G, Zeeb H. Is cancer risk of radiation workers larger than expected? Occup Environ Med 2009; 66:789-96
25. The 2007 recommendations of the ICRP-Publication 103. Annex A. Biological and epidemiological information on health risks attributable to ionising radiation. Ann ICRP 2007; 37:137-246.
26. Yamamoto O, Antoku S, Russell WJ, Fujita S, Sawada S. Medical X-ray exposure doses as possible contaminants of atomic bomb doses. TR 16-86. Hiroshima: Radiation Effects Research Foundation; 1986.
27. Cologne JB, Preston DL. Longevity of atomic-bomb survivors. Lancet 2000; 356:303-7. (Pubitemid 30459589)
28. Cologne JB, Preston DL. Impact of comparison group on cohort dose response regression: an example using risk estimation in atomic-bomb survivors. Health Phys 2001; 80:491-6. (Pubitemid 32295301)
29. Furukawa K, Preston DL, Lönn S, Funamoto S, Yonehara S, Matsuo T, et al. Radiation and smoking effects on lung cancer incidence among atomic bomb survivors. Radiat Res 2010; 174:72-82.
30. Sharp GB, Mizuno T, Cologne JB, Fukuhara T, Fujiwara S, Tokuoka S, et al. Hepatocellular carcinoma among atomic bomb survivors: significant interaction of radiation with hepatitis C virus infections. Int J Cancer 2003; 103:531-7. (Pubitemid 36020230)
31. Ohishi W, Fujiwara S, Cologne JB, Suzuki G, Akahoshi M, Nishi N, et al. Impact of radiation and hepatitis virus infection on risk of hepatocellular carcinoma. Hepatology 2011; 53:1237-45.
32. Folley JH, Borges W, Yamawaki T. Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan. Am J Med 1952; 13:311-21.
33. Richardson D, Sugiyama H, Wing S, Sakata R, Grant EJ, Shimizu Y, et al. Positive associations between ionizing radiation and lymphoma mortality among men. Am J Epidemiol 2009; 169:969-76.
34. Pierce DA, Shimizu Y, Preston DL, Vaeth M, Mabuchi K. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990. Radiat Res 1996; 146:1-27. (Pubitemid 26230829)
35. Preston DL, Kusumi S, Tomonaga M, Izumi S, Ron E, Kuramoto A, et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res 1994; 137 Suppl:S68-97. (Pubitemid 24060247)
36. Shimizu Y, Kodama K, Nishi N, Kasagi F, Suyama A, Soda M, et al. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003. BMJ 2010; 340:b5349.